Covid-19 roundup: J&J gives deepest look yet at vaccine; AstraZeneca shies away from discussing vaccine commercial opportunity
J&J has given its deepest look yet into its coronavirus vaccine candidate.
The NJ pharma and Operation Warp Speed member published the preclinical results for their vaccine in Nature Thursday morning, showing that a single dose provided “complete or near-complete protection” from SARS-CoV-2 in rhesus macaques. The results bolstered a Phase I trial that is already underway, having launched in Belgium and the US.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.